Commercialization, run as one connected system.

Nora is a new product commercialization expert across specialty, oncology and primary care markets. Her HCP, institutional and payer marketing expertise lets her integrate teams, perspectives and strategic direction so each brand reaches its full potential.

She has led initiatives to build patient navigation platforms that gain access and coverage for uninsured and underinsured patients, and she knows healthcare reform, value-based benefit design, payment reform and quality improvement well.

Over more than 20 years she has led field-based collaborative initiatives with large medical and oncology group practices, comprehensive cancer centers, hospital systems and professional health organizations. At Pfizer she led the initial alignment of payer access messaging and targeting across managed markets, marketing and sales.

Experience

Managing Director, Patient Access and Commercialization. Jennifer’s career spans every seat in patient access: health plan, PBM and specialty pharmacy, access technology and biopharma commercialization, most recently at IQVIA.

She is a trusted product-development partner, shaping access-technology roadmaps from the field’s point of view, with deep, active relationships across U.S. pharmaceutical manufacturers and the access-technology vendor landscape. She has a consistent record of exceeding performance goals in every role she has held.

Core expertise: patient hub design and patient access infrastructure, ePA and eBV workflows, specialty pharmacy, 340B and medical rebates, Gross-to-Net, access-technology relationship management, patient services design, and the vendor landscape (BI/BV, patient hub CRM, agentic AI).

Experience

Managing Director, Pricing, Contracting and Gross-to-Net Transformation. Julie brings more than 25 years of biopharmaceutical leadership across the full commercial-finance value chain, from Gross-to-Net transformation and revenue management modernization to pricing and contracting strategy and specialty product launches across immunology, oncology and other specialty portfolios. She brings IRA-era government pricing fluency (MFP and MFN policy dynamics) and a record of building vendor evaluations, transformation roadmaps and go-to-market strategies for multi-billion-dollar portfolios.

She advises on Gross-to-Net transformation, forecast-to-accrual and MDM and golden-record data strategy. She has guided launch pricing and contracting strategy, including the launches of vedolizumab in inflammatory bowel disease and peginesatide in renal care. She supports revenue management system selection, including a Model N implementation still in production today, and builds pricing and contract strategy across commercial, Medicare, Medicaid, specialty pharmacy, retail and federal markets, with compliance across AMP, Best Price, ASP and 340B reporting.

Core expertise: pricing strategy and governance, WAC and price corridor design, biosimilar competitive positioning, buy-and-bill, pricing committee governance, data strategy, class of trade strategy, trade and GPO contracting, PBM and payer contracting and economics, outcomes-based and value-based contracting, government price reporting (AMP, Best Price, ASP, 340B), VA and FSS contracting, Gross-to-Net forecasting and accrual management, and IRA, MFP and MFN (GENEROUS, GLOBE, GUARD).

Experience

Jeff makes difficult projects succeed by drawing on business strategy, claims analysis, customer engagement and contracting. He has created, negotiated and executed a strong portfolio of innovative agreements.

He has worked in strategic and operational roles across market access strategy, national account engagement and contracting, and built three teams at GSK, each with a new capability: population analysis, economic value communication to national accounts, and innovative payer contracting.

Jeff earned his MS in Economics at North Carolina State University and was a visiting scholar in behavioral economics at Duke University.

Experience

Najur is responsible for the definition, execution and delivery of go-to-market, product launch, digital transformation, commercial operations and data and technology projects.

He has delivered complex, multi-disciplinary commercial, analytical, AI and data solutions across many therapeutic areas, including small molecules, biologics, vaccines and oncology platforms, over a career of more than 20 years across the life sciences ecosystem.

He studied Mechanical Engineering at the University of Minnesota and Statistics and Economics at the University of St. Thomas.

Experience

Wilmer oversees a team of skilled project managers and a diverse project portfolio. He is regularly called on to address critical situations and lead risk management so projects deliver.

He has worked across private and public sectors, including health insurers, hospitals, financial institutions, banking, marketing, avionics and pharmaceutical companies. Wilmer holds a BA/BS from the State University of New York.

Experience

Tommy helps the office of finance analyze, design and implement the right solutions, and orchestrates applied technology to solve finance problems. He brings deep expertise in designing and delivering enterprise performance management for management reporting, planning and modeling.

He leads small direct teams that integrate with larger client teams, with hands-on involvement in every phase. He has spent more than 11 years as a solutions architect delivering planning outcomes to more than 100 clients, and five years administering Hyperion Essbase implementations.

Experience